Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The NIH-funded research focuses on chronic conditions other than HIV and examines gender differences.
In a win for abortion opponents, the Trump administration limits funding of research using fetal tissue.
Portland State University researchers are partnering with transgender women throughout the process.
Women make up half of the HIV population, but the virus affects them differently than men.
Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!
Gilead Sciences CEO defends high drug prices and claims the CDC does not own the patent to HIV prevention pill Truvada.
Global research teams from three U.S. universities explore this HIV-tuberculosis link, thanks to a $6.2 million grant.
The amfAR funding goes to scientists using nanotechnology and protein “fingerprinting.”
An all-female panel of amfAR-funded HIV scientists share insights on sex differences in the HIV reservoir, gender in research and more.
Samuel Weissman won second place at the 2019 Regeneron Science Talent Search. Next, he wants to help cure HIV.
For over 30 years, the California-based group fought for treatments, research, education and quality health care.
A group of “immunological nonresponders” wants the FDA to grant them orphan disease status.
The new federal initiative will work with existing research programs in eight cities.
Because the scientists use fetal tissue.
The study hopes to understand why Black women, who are at higher risk for HIV, are not likely to take PrEP.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.